Literature DB >> 16498511

Cellular cholesterol homeostasis in vascular endothelial cells.

Hajj Hassan Hassan1, Maxime Denis, Larbi Krimbou, Michel Marcil, Jacques Genest.   

Abstract

Atherosclerosis is a disease of blood vessel walls that is thought to be initiated as a reaction of insults to the endothelium. The complex sequence of cellular events that begins with focal inflammation leads to the accumulation of leukocytes in the subendothelial layer and unrestricted uptake of oxidized lipoproteins by macrophages and smooth muscle cells, leading to foam cell formation. Vascular endothelial cells do not undergo the foam cell transformation and do not accumulate cholesterol in atherosclerotic plaques to the same extent as macrophages or smooth muscle cells. However, vascular endothelial cells express receptors for oxidized lipoproteins, and have the biochemical pathways for sterol synthesis and receptor-mediated endocytosis of lipoproteins. Data from the authors' laboratory show that high density lipoproteins but not lipid-free apolipoprotein A-I promote cellular cholesterol efflux in human umbilical vascular endothelial cells and human aortic endothelial cells. Gene expression microarrays were used to examine the differential expression of genes after cholesterol loading. While sterol regulatory element-binding protein-sensitive genes were downregulated, the authors identified a novel transporter, the ATP-binding cassette G1 (ABCG1) to be highly expressed in response to both cellular cholesterol loading and stimulation with the liver X receptor agonist 22-hydroxycholesterol. The ABCA1 gene and protein, the major modulator of cellular cholesterol efflux in macrophages and in peripheral and hepatic tissues, are only weakly expressed in human umbilical vascular endothelial cells and human aortic endothelial cells. These data suggest that endothelial cells maintain cholesterol homeostasis by downregulating cholesterol synthesis and low density lipoprotein receptors and by a cellular cholesterol efflux mechanism onto low-affinity but high-capacity high density lipoproteins. The role of ABC-type transporters, including ABCG1, requires further examination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498511      PMCID: PMC2780830          DOI: 10.1016/s0828-282x(06)70985-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  37 in total

Review 1.  High-density lipoproteins and endothelial function.

Authors:  B J O'Connell; J Genest
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  Cellular localization and trafficking of the human ABCA1 transporter.

Authors:  E B Neufeld; A T Remaley; S J Demosky; J A Stonik; A M Cooney; M Comly; N K Dwyer; M Zhang; J Blanchette-Mackie; S Santamarina-Fojo; H B Brewer
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

3.  ABCG4: a novel human white family ABC-transporter expressed in the brain and eye.

Authors:  Susan Oldfield; Christopher Lowry; Jon Ruddick; Stafford Lightman
Journal:  Biochim Biophys Acta       Date:  2002-08-19

Review 4.  Atheroprotective effects of high-density lipoproteins.

Authors:  Gerd Assmann; Jerzy-Roch Nofer
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

5.  Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.

Authors:  M Marcil; A Brooks-Wilson; S M Clee; K Roomp; L H Zhang; L Yu; J A Collins; M van Dam; H O Molhuizen; O Loubster; B F Ouellette; C W Sensen; K Fichter; S Mott; M Denis; B Boucher; S Pimstone; J Genest; J J Kastelein; M R Hayden
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

Review 6.  Role of ABCG1 and other ABCG family members in lipid metabolism.

Authors:  G Schmitz; T Langmann; S Heimerl
Journal:  J Lipid Res       Date:  2001-10       Impact factor: 5.922

7.  Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.

Authors:  G W Cockerill; T Y Huehns; A Weerasinghe; C Stocker; P G Lerch; N E Miller; D O Haskard
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

8.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

9.  Human and mouse orthologs of a new ATP-binding cassette gene, ABCG4.

Authors:  T Annilo; J Tammur; A Hutchinson; A Rzhetsky; M Dean; R Allikmets
Journal:  Cytogenet Cell Genet       Date:  2001

10.  High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

Authors:  A Uittenbogaard; P W Shaul; I S Yuhanna; A Blair; E J Smart
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

View more
  19 in total

1.  Overexpression of the steroidogenic acute regulatory protein increases the expression of ATP-binding cassette transporters in microvascular endothelial cells (bEnd.3).

Authors:  Yan-Xia Ning; Shun-Lin Ren; Feng-di Zhao; Lian-Hua Yin
Journal:  J Zhejiang Univ Sci B       Date:  2010-05       Impact factor: 3.066

2.  Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation.

Authors:  Julie K Freed; Andreas M Beyer; John A LoGiudice; Joseph C Hockenberry; David D Gutterman
Journal:  Circ Res       Date:  2014-06-11       Impact factor: 17.367

3.  High Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis.

Authors:  Sushant Tripathy; Elena Vinokour; Kaylin M McMahon; Olga V Volpert; C Shad Thaxton
Journal:  Part Part Syst Charact       Date:  2014-11-01       Impact factor: 3.310

4.  Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.

Authors:  Boris L Vaisman; Stephen J Demosky; John A Stonik; Mona Ghias; Cathy L Knapper; Maureen L Sampson; Cuilian Dai; Stewart J Levine; Alan T Remaley
Journal:  J Lipid Res       Date:  2011-10-27       Impact factor: 5.922

5.  ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions.

Authors:  Angela M Whetzel; Jeffrey M Sturek; Melissa H Nagelin; David T Bolick; Abraham K Gebre; John S Parks; Anthony C Bruce; Marcus D Skaflen; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-28       Impact factor: 8.311

6.  Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery.

Authors:  Kalina Paunovska; Carmen J Gil; Melissa P Lokugamage; Cory D Sago; Manaka Sato; Gwyn N Lando; Marielena Gamboa Castro; Anton V Bryksin; James E Dahlman
Journal:  ACS Nano       Date:  2018-07-20       Impact factor: 15.881

Review 7.  Emerging new paradigms for ABCG transporters.

Authors:  Paul T Tarr; Elizabeth J Tarling; Dragana D Bojanic; Peter A Edwards; Angel Baldán
Journal:  Biochim Biophys Acta       Date:  2009-01-22

8.  Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.

Authors:  Jianghong Chen; Li Zhao; Dongdong Sun; Kazim Narsinh; Chunhong Li; Zheng Zhang; Shun Qi; Guangquan Wei; Weijie Li; Wenyi Guo; Feng Cao
Journal:  Inflamm Res       Date:  2012-07-26       Impact factor: 4.575

9.  Single-Cell Transcriptomics Reveals Endothelial Plasticity During Diabetic Atherogenesis.

Authors:  Guizhen Zhao; Haocheng Lu; Yuhao Liu; Yang Zhao; Tianqing Zhu; Minerva T Garcia-Barrio; Y Eugene Chen; Jifeng Zhang
Journal:  Front Cell Dev Biol       Date:  2021-05-19

10.  Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits.

Authors:  Götz Münch; Andreas Bültmann; Zhongmin Li; Hans-Peter Holthoff; Julia Ullrich; Silvia Wagner; Martin Ungerer
Journal:  Heart Int       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.